|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 37/02 | |
| C07K 16/00 | |||
| A01K 67/027 | |||
| C07K 16/46 | |||
| C12N 15/85 |
| (11) | Number of the document | 3028564 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16151214.0 |
| Date of filing the European patent application | 2010-07-07 | |
| (97) | Date of publication of the European application | 2016-06-08 |
| (45) | Date of publication and mention of the grant of the patent | 2017-09-27 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 0911846 | 2009-07-08 | GB | |
| 223960 P | 2009-07-08 | US | |
| 0913102 | 2009-07-28 | GB | |
| 355666 P | 2010-06-17 | US |
| (72) |
BRADLEY, Allan, GB
LEE, E-Chiang, GB
LIANG, Qi, GB
WANG, Wei, GB
|
| (73) |
Kymab Limited,
The Bennet Building (B930) Babraham Research Campus, Cambridge CB22 3AT,
GB
|
| (54) | ANIMAL MODELS AND THERAPEUTIC MOLECULES |
| ANIMAL MODELS AND THERAPEUTIC MOLECULES |